The DOI matches its Crossref record; 260 of the 260 references it cites were found in a registry or an index.
Candida Infections and Therapeutic Strategies: Mechanisms of Action for Traditional and Alternative Agents
Open accessAbstract
The Candida genus comprises opportunistic fungi that can become pathogenic when the immune system of the host fails. Candida albicans is the most important and prevalent species. Polyenes, fluoropyrimidines, echinocandins, and azoles are used as commercial antifungal agents to treat candidiasis. However, the presence of intrinsic and developed resistance against azole antifungals has been extensively documented among several Candida species. The advent of original and re-emergence of classical fungal diseases have occurred as a consequence of the development of the antifungal resistance phenomenon. In this way, the development of new satisfactory therapy for fungal diseases persists as a major challenge of present-day medicine. The design of original drugs from traditional medicines provides new promises in the modern clinic. The urgent need includes the development of alternative drugs that are more efficient and tolerant than those traditional already in use. The identification of new substances with potential antifungal effect at low concentrations or in combination is also a possibility. The present review briefly examines the infections caused by Candida species and focuses on the mechanisms of action associated with the traditional agents used to treat those infections, as well as the current understanding of the molecular basis of resistance development in these fungal species. In addition, this review describes some of the promising alternative molecules and/or substances that could be used as anticandidal agents, their mechanisms of action, and their use in combination with traditional drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Newman, D. J., & Cragg, G. M. (2012) · Journal of Natural Products · doi:10.1021/np200906s · Cited by 4,687
Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
Pfaller, M. A., & Diekema, D. J. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00029-06 · Cited by 4,174 · cited 1×
“and is the most relevant and prevalent nosocomial fungal infection associated with a high mortality rate (up to 49%) in patients with a compromised immune system (Pfaller and Diekema, 2007; Sardi et al., 2013).”
BackgroundPappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191
Pao, S. S., Paulsen, I. T., & Saier, M. H. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.1-34.1998 · Cited by 2,297
Candida albicans pathogenicity mechanisms
Mayer, F. L., Wilson, D., & Hube, B. (2013) · Virulence · doi:10.4161/viru.22913 · Cited by 1,848
Polyphenols as antimicrobial agents
Daglia, M. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2011.08.007 · Cited by 1,637
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Virulence factors of Candida albicans
Calderone, R. A., & Fonzi, W. A. (2001) · Trends in Microbiology · doi:10.1016/s0966-842x(01)02094-7 · Cited by 1,331
Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217
Sardi, J. C. O., Scorzoni, L., Bernardi, T., Fusco-Almeida, A. M., & Mendes Giannini, M. J. S. (2013) · Journal of Medical Microbiology · doi:10.1099/jmm.0.045054-0 · Cited by 1,184
Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171
Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment
Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903
Vermes, A. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/46.2.171 · Cited by 803
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Pfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692
Clancy, C. J., & Nguyen, M. H. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit006 · Cited by 688
Parczewska, O. K., Posaconazol, przeciwgrzybicze, L., Anidulafungina, Micafungina, & wrażliwość, O. (2009) · Cited by 656
Mechanisms of Antifungal Drug Resistance
Cowen, L. E., Sanglard, D., Howard, S. J., Rogers, P. D., & Perlin, D. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019752 · Cited by 647
Resistance to Antifungal Agents: Mechanisms and Clinical Impact
Kanafani, Z. A., & Perfect, J. R. (2008) · Clinical Infectious Diseases · doi:10.1086/524071 · Cited by 619
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Hise, A. G., Tomalka, J., Ganesan, S., Patel, K., Hall, B. A., Brown, G. D., & Fitzgerald, K. A. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.05.002 · Cited by 568
Antifungal drug resistance of pathogenic fungi
Kontoyiannis, D. P., & Lewis, R. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08162-x · Cited by 553
Resistance to echinocandin-class antifungal drugs.
Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512
Candida albicans, a major human fungal pathogen
Kim, J., & Sudbery, P. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-1064-7 · Cited by 488
Reichling, J., Schnitzler, P., Suschke, U., & Saller, R. (2009) · Complementary Medicine Research · doi:10.1159/000207196 · Cited by 482
Reduction of disulphide bonds unmasks potent antimicrobial activity of human β-defensin 1
Schroeder, B. O., Wu, Z., Nuding, S., Groscurth, S., Marcinowski, M., Beisner, J., Buchner, J., Schaller, M., Stange, E. F., & Wehkamp, J. (2011) · Nature · doi:10.1038/nature09674 · Cited by 457
Emerging Threats in Antifungal-Resistant Fungal Pathogens
Sanglard, D. (2016) · Frontiers in Medicine · doi:10.3389/fmed.2016.00011 · Cited by 416
Spampinato, C., & Leonardi, D. (2013) · BioMed Research International · doi:10.1155/2013/204237 · Cited by 411
Coste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407
Sanglard, D., Ischer, F., Parkinson, T., Falconer, D., & Bille, J. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2404-2412.2003 · Cited by 398
Pfaller, M. A., Andes, D. R., Diekema, D. J., Horn, D. L., Reboli, A. C., Rotstein, C., Franks, B., & Azie, N. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101510 · Cited by 396
Antifungal drug resistance among Candida species: mechanisms and clinical impact
Sanguinetti, M., Posteraro, B., & Lass‐Flörl, C. (2015) · Mycoses · doi:10.1111/myc.12330 · Cited by 394
Coste, A., Turner, V., Ischer, F., Morschhäuser, J., Forche, A., Selmecki, A., Berman, J., Bille, J., & Sanglard, D. (2006) · Genetics · doi:10.1534/genetics.105.054767 · Cited by 385
Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999) · Microbiology · doi:10.1099/00221287-145-10-2701 · Cited by 382
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
The antimicrobial activity of lactoferrin: Current status and perspectives
Orsi, N. (2004) · Biometals · doi:10.1023/b:biom.0000027691.86757.e2 · Cited by 368
Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362
Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030164 · Cited by 355
Nett, J. E., & Andes, D. R. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.012 · Cited by 351
Schibli, D. J., Hunter, H. N., Aseyev, V., Starner, T. D., Wiencek, J. M., McCray, P. B., Tack, B. F., & Vogel, H. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108830200 · Cited by 347
Franz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3065 · Cited by 339
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337
Clinical Appearance of Oral Candida Infection and Therapeutic Strategies
Patil, S., Rao, R. S., Majumdar, B., & Anil, S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.01391 · Cited by 324
The Structure of Human β-Defensin-2 Shows Evidence of Higher Order Oligomerization
Hoover, D. M., Rajashankar, K. R., Blumenthal, R., Puri, A., Oppenheim, J. J., Chertov, O., & Lubkowski, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006098200 · Cited by 321
Terpenoids inhibit Candida albicans growth by affecting membrane integrity and arrest of cell cycle
Zore, G. B., Thakre, A. D., Jadhav, S., & Karuppayil, S. M. (2011) · Phytomedicine · doi:10.1016/j.phymed.2011.03.008 · Cited by 319
Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R., & Fadda, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.668-679.2005 · Cited by 319
Biofilm lifestyle of Candida: a mini review
Seneviratne, C., Jin, L., & Samaranayake, L. (2008) · Oral Diseases · doi:10.1111/j.1601-0825.2007.01424.x · Cited by 317
Mechanisms of echinocandin antifungal drug resistance
Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313
It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug
Mesa-Arango, A. C., Scorzoni, L., & Zaragoza, O. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00286 · Cited by 311
Antifungal drug resistance to azoles and polyenes
Canuto, M. M., & Rodero, F. G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00371-7 · Cited by 310
Combination Treatment of Invasive Fungal Infections
Mukherjee, P. K., Sheehan, D. J., Hitchcock, C. A., & Ghannoum, M. A. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.1.163-194.2005 · Cited by 308
Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03470-14 · Cited by 294
The global burden of fungal diseases
Vallabhaneni, S., Mody, R. K., Walker, T., & Chiller, T. (2016) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2015.10.004 · Cited by 292
Kontoyiannis, D. P., Hachem, R., Lewis, R. E., Rivero, G. A., Torres, H. A., Thornby, J., Champlin, R., Kantarjian, H., Bodey, G. P., & Raad, I. I. (2003) · Cancer · doi:10.1002/cncr.11479 · Cited by 287
Sanglard, D., Coste, A., & Ferrari, S. (2009) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2009.00578.x · Cited by 285
Hertz, C. J., Wu, Q., Porter, E. M., Zhang, Y. J., Weismüller, K.-H., Godowski, P. J., Ganz, T., Randell, S. H., & Modlin, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6820 · Cited by 285
Artymiuk, P. J., & Blake, C. C. F. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90125-x · Cited by 285
A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality.
Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Cecilia, T., De Pascale, G., Diaz-Martin, A., Luzzati, R., Rosin, C., Lagunes, L., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3310-z · Cited by 284
Morio, F., Loge, C., Besse, B., Hennequin, C., & Le Pape, P. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.11.006 · Cited by 279
Structure–activity relationship of antibacterial chalcones
Ávila, H. P., Smânia, E. D. F. A., Monache, F. D., & Smânia, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.09.064 · Cited by 276
Current Perspectives on Echinocandin Class Drugs
Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.19 · Cited by 274
Introduction to Antifungal Drugs
Dismukes, W. E. (2000) · Clinical Infectious Diseases · doi:10.1086/313748 · Cited by 262
Martins, N., Barros, L., Santos-Buelga, C., Henriques, M., Silva, S., & Ferreira, I. C. F. R. (2015) · Food Chemistry · doi:10.1016/j.foodchem.2014.08.096 · Cited by 258
The major facilitator superfamily.
Saier, M. H., Beatty, J. T., Goffeau, A., Harley, K. T., Heijne, W. H., Sc, H., Jack, D. L., Jähn, P. S., Lew, K., Liu, J., et al. (1999) · PubMed · Cited by 256
Azole antifungals: 35 years of invasive fungal infection management
Allen, D., Wilson, D., Drew, R., & Perfect, J. (2015) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2015.1032939 · Cited by 255
The Cathelicidins - Structure, Function and Evolution
Tomasinsig, L., & Zanetti, M. (2005) · Current Protein & Peptide Science · doi:10.2174/1389203053027520 · Cited by 254
Wächtler, B., Citiulo, F., Jablonowski, N., Förster, S., Dalle, F., Schaller, M., Wilson, D., & Hube, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036952 · Cited by 250
Expression of β‐defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells
Duits, L. A., Ravensbergen, B., Rademaker, M., Hiemstra, P. S., & Nibbering, P. H. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01430.x · Cited by 249
Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247
Differential Regulation of β-Defensin Expression in Human Skin by Microbial Stimuli
Sørensen, O. E., Thapa, D. R., Rosenthal, A., Liu, L., Roberts, A. A., & Ganz, T. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4870 · Cited by 244
Two unlike cousins: Candida albicans and C . glabrata infection strategies
Brunke, S., & Hube, B. (2013) · Cellular Microbiology · doi:10.1111/cmi.12091 · Cited by 239
Pfaller, M. A., Messer, S. A., Woosley, L. N., Jones, R. N., & Castanheira, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00308-13 · Cited by 237
de Castro, R. D., de Souza, T. M. P. A., Bezerra, L. M. D., Ferreira, G. L. S., de Brito Costa, E. M. M., & Cavalcanti, A. L. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0947-2 · Cited by 225
Antifungals: mechanism of action and resistance, established and novel drugs
Georgopapadakou, N. H. (1998) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(98)80087-8 · Cited by 224
Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis
Bennett, J. E., Izumikawa, K., & Marr, K. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1773-1777.2004 · Cited by 217
Role of Candida albicans Transcription Factor Upc2p in Drug Resistance and Sterol Metabolism
Silver, P. M., Oliver, B. G., & White, T. C. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1391-1397.2004 · Cited by 216
Molecular biological characterization of an azole-resistant Candida glabrata isolate
Marichal, P., Vanden Bossche, H., Odds, F. C., Nobels, G., Warnock, D. W., Timmerman, V, Van Broeckhoven, C., Fay, S., & Mose-Larsen, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2229 · Cited by 210
Lopez-Ribot, J. L., McAtee, R. K., Lee, L. N., Kirkpatrick, W. R., White, T. C., Sanglard, D., & Patterson, T. F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.11.2932 · Cited by 210
Epidemiology of candidemia in intensive care units
Bouza, E., & Muñoz, P. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70006-2 · Cited by 207
Antifungal agents: mode of action in yeast cells.
Carrillo‐Muñoz, A. J., Giusiano, G., Ezkurra, P. A., & Quindós, G. (2006) · PubMed · Cited by 203
Moran, G. P., Sanglard, D., Donnelly, S. M., Shanley, D. B., Sullivan, D. J., & Coleman, D. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1819 · Cited by 197
In vitro activity of terpenes against Candida biofilms
Dalleau, S., Cateau, E., Bergès, T., Berjeaud, J.-M., & Imbert, C. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.01.028 · Cited by 195
Schwarzmüller, T., Ma, B., Hiller, E., Istel, F., Tscherner, M., Brunke, S., Ames, L., Firon, A., Green, B., Cabral, V., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004211 · Cited by 191
The Structure of Human β-Defensin-1
Hoover, D. M., Chertov, O., & Lubkowski, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103830200 · Cited by 191
Katiyar, S., Pfaller, M., & Edlind, T. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00349-06 · Cited by 189
Oral candidosis – Clinical challenges of a biofilm disease
Rautemaa, R., & Ramage, G. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.585606 · Cited by 188
De Lira Mota, K., De Oliveira Pereira, F., De Oliveira, W., Lima, I., & De Oliveira Lima, E. (2012) · Molecules · doi:10.3390/molecules171214418 · Cited by 187
Antifungals: Mechanism of Action and Drug Resistance
Prasad, R., Shah, A. H., & Rawal, M. K. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-25304-6_14 · Cited by 183
Multidrug Resistance in Yeast Candida
Prasad, R., & Kapoor, K. (2004) · International Review of Cytology · doi:10.1016/s0074-7696(04)42005-1 · Cited by 180
Pfaller, M. A., Castanheira, M., Messer, S. A., Moet, G. J., & Jones, R. N. (2010) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.06.015 · Cited by 180
Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus
Gonçalves, S. S., Souza, A. C. R., Chowdhary, A., Meis, J. F., & Colombo, A. L. (2016) · Mycoses · doi:10.1111/myc.12469 · Cited by 180
Seleem, D., Pardi, V., & Murata, R. M. (2017) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.08.030 · Cited by 179
Invasive Fungal Infections in Solid Organ Transplant Recipients
Shoham, S., & Marr, K. A. (2012) · Future Microbiology · doi:10.2217/fmb.12.28 · Cited by 178
Tsai, P.-W., Yang, C.-Y., Chang, H.-T., & Lan, C.-Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017755 · Cited by 175
Xu, Y., Burton, S., Kim, C., & Sismour, E. (2016) · Food Science & Nutrition · doi:10.1002/fsn3.264 · Cited by 175
Invasive Fungal Infections in the ICU: How to Approach, How to Treat
Paramythiotou, E., Frantzeskaki, F., Flevari, A., Armaganidis, A., & Dimopoulos, G. (2014) · Molecules · doi:10.3390/molecules19011085 · Cited by 175
Chen, S. C. A., & Sorrell, T. C. (2007) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2007.tb01313.x · Cited by 175
Efflux pump proteins in antifungal resistance
Prasad, R., & Rawal, M. K. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00202 · Cited by 173 · cited 2×
“Mutations Associated With Efflux Pump Genes (CDR1, CDR2, and MDR1) and Transcription Factors An important and potent mechanism of multi-drug resistance (MDR) in fungi is the intracellular accumulation of antifungals by increased efflux of drugs (Prasad and Kapoor, 2005; Prasad and Rawal, 2014).”
BackgroundNew and emerging treatments for fungal infections
Pasqualotto, A. C., & Denning, D. W. (2008) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm428 · Cited by 173
Guery, B. P., Arendrup, M. C., Auzinger, G., Azoulay, É., Borges Sá, M., Johnson, E. M., Müller, E., Putensen, C., Rotstein, C., Sganga, G., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-008-1338-7 · Cited by 173
Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans
Cui, J., Ren, B., Tong, Y., Dai, H., & Zhang, L. (2015) · Virulence · doi:10.1080/21505594.2015.1039885 · Cited by 171
Chamilos, G., Lewis, R. E., Albert, N., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00095-07 · Cited by 171
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., Warrilow, A. G. S., Kelly, D. E., & Kelly, S. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00303-10 · Cited by 165
Miyazaki, H., Miyazaki, Y., Geber, A., Parkinson, T., Hitchcock, C., Falconer, D. J., Ward, D. J., Marsden, K., & Bennett, J. E. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1695 · Cited by 162
Clinical pharmacology of antifungal compounds
Groll, A. H., Gea‐Banacloche, J., Glasmacher, A., Just‐Nübling, G., Maschmeyer, G., & Walsh, T. J. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00068-5 · Cited by 157
Candida and Host Determinants of Susceptibility to Invasive Candidiasis
Lionakis, M. S., & Netea, M. G. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003079 · Cited by 157
Mechanisms of azole resistance in 52 clinical isolates of Candida tropicalis in China
Jiang, C., Dong, D., Yu, B., Cai, G., Wang, X., Ji, Y., & Peng, Y. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks481 · Cited by 153
Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?
Maubon, D., Garnaud, C., Calandra, T., Sanglard, D., & Cornet, M. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3404-7 · Cited by 145
Mechanisms of Azole Resistance in a Clinical Isolate of Candida tropicalis
Vandeputte, P., Larcher, G., Bergès, T., Rénier, G., Chabasse, D., & Bouchara, J. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4608-4615.2005 · Cited by 143
Mecanismos de resistencia a los antifúngicos: levaduras y hongos filamentosos
Espinel‐Ingroff, A. (2008) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(08)70027-5 · Cited by 142
Torelli, R., Posteraro, B., Ferrari, S., La Sorda, M., Fadda, G., Sanglard, D., & Sanguinetti, M. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06143.x · Cited by 141
Activity of phenolic compounds from plant origin against Candida species
Martins, N. A., Barros, L., Henriques, M., Silva, S. M., & Ferreira, I. C. F. R. (2015) · Industrial Crops and Products · doi:10.1016/j.indcrop.2015.05.067 · Cited by 139
Mondello, F., Bernardis, F. D., Girolamo, A., Salvatore, G., & Cassone, A. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg202 · Cited by 136
Natural Antimicrobial Peptides as Inspiration for Design of a New Generation Antifungal Compounds
Bondaryk, M., Staniszewska, M., Zielińska, P., & Urbańczyk-Lipkowska, Z. (2017) · Journal of Fungi · doi:10.3390/jof3030046 · Cited by 133
Recent advances in antifungal chemotherapy
Petrikkos, G. L., & Skiada, A. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.03.009 · Cited by 128
Tsao, S., Rahkhoodaee, F., & Raymond, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00926-08 · Cited by 126
Antifungal drug resistance mechanisms
Pemán, J., Cantón, E., & Espinel‐Ingroff, A. (2009) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.09.18 · Cited by 126
de Toledo, L. G., Ramos, M. A. D. S., Spósito, L., Castilho, E. M., Pavan, F. R., Lopes, É. O., Zocolo, G. J., Silva, F., Soares, T., dos Santos, A. G., et al. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081252 · Cited by 125
Utilising polyphenols for the clinical management of Candida albicans biofilms
Shahzad, M. A., Sherry, L., Rajendran, R., Edwards, C. A., Combet, E., & Ramage, G. (2014) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2014.05.017 · Cited by 122
Souza, A. C. R., Fuchs, B. B., Pinhati, H. M. S., Siqueira, R. A., Hagen, F., Meis, J. F., Mylonakis, E., & Colombo, A. L. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01177-15 · Cited by 121
Structure of human diferric lactoferrin refined at 2.2 Å resolution
Haridas, M., Anderson, B. F., & Baker, E. N. (1995) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994013521 · Cited by 121
Rationale for Combination Antifungal Therapy
Lewis, R. E., & Kontoyiannis, D. P. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.12.149s.34505 · Cited by 118
Grossman, N. T., Pham, C. D., Cleveland, A. A., & Lockhart, S. R. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04613-14 · Cited by 112
In vitro antifungal activity of the flavonoid baicalein against Candida species
Serpa, R., de França, E. J. G., Furlaneto-Maia, L., Andrade, C. G. T. J., Diniz, A., & Furlaneto, M. C. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.047852-0 · Cited by 112
MFS transportome of the human pathogenic yeast Candida albicans
Gaur, M., Puri, N., Manoharlal, R., Rai, V., Mukhopadhayay, G., Choudhury, D., & Prasad, R. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-579 · Cited by 110
Krishnakumari, V., Rangaraj, N., & Nagaraj, R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00470-08 · Cited by 110
Drug-Induced Nephrotoxicity Caused by Amphotericin B Lipid Complex and Liposomal Amphotericin B
Safdar, A., Ma, J., Saliba, F., Dupont, B., Wingard, J. R., Hachem, R. Y., Mattiuzzi, G. N., Chandrasekar, P. H., Kontoyiannis, D. P., Rolston, K. V. I., et al. (2010) · Medicine · doi:10.1097/md.0b013e3181e9441b · Cited by 108
New generation azole antifungals in clinical investigation
Girmenia, C. (2009) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780903176407 · Cited by 107
Wound repair and anti-inflammatory potential of Lonicera japonica in excision wound-induced rats
Chen, W.-C., Liou, S., Tzeng, T., Lee, S., & Liu, I.-M. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-226 · Cited by 106
Espinel-Ingroff, A. (2009) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(09)70004-x · Cited by 105
Oral colonization by yeasts in HIV-positive patients in Brazil
Junqueira, J. C., Vilela, S. F. G., Rossoni, R. D., Barbosa, J. O., Costa, A. C. B. P., Rasteiro, V. M. C., Suleiman, J. M. A. H., & Jorge, A. O. C. (2012) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652012000100004 · Cited by 105
Oxman, D., Chow, J. K. L., Frendl, G., Hadley, S., Hershkovitz, S., Ireland, P., McDermott, L. A., Tsai, K., Marty, F. M., Kontoyiannis, D. P., et al. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq136 · Cited by 105
Surface activity of thymol: implications for an eventual pharmacological activity
Sánchez, M. E., Turina, A. V., García, D. A., Nolan, M. V., & Perillo, M. A. (2004) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2003.11.007 · Cited by 104
Identification and expression of multidrug resistancerelated ABC transporter genes in Candida krusei
Katiyar, S. K., & Edlind, T. D. (2001) · Medical Mycology · doi:10.1080/mmy.39.1.109.116 · Cited by 104
Salivary Histatin 5 and its Similarities to the Other Antimicrobial Proteins in Human Saliva
Edgerton, M., & Koshlukova, S. E. (2000) · Advances in Dental Research · doi:10.1177/08959374000140010201 · Cited by 104
Mulaudzi, R. B., Ndhlala, A. R., Kulkarni, M. G., & Staden, J. V. (2012) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2012.06.022 · Cited by 103
Antifúngicos: mecanismo de acción en células de levaduras
Quindós, G., Giusiano, G., Ezkurra, P. A., & Muñoz, A. J. C. (2006) · Revista española de quimioterapia. Suplemento · Cited by 102
Lamping, E., Ranchod, A., Nakamura, K., Tyndall, J. D. A., Niimi, K., Holmes, A. R., Niimi, M., & Cannon, R. D. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01095-08 · Cited by 100
Todorović, V., Milenković, M., Vidović, B. B., Todorović, Z. B., & Sobajic, S. S. (2017) · Journal of Food Science · doi:10.1111/1750-3841.13672 · Cited by 100
β-Defensin 1 Plays a Role in Acute Mucosal Defense against Candida albicans
Tomalka, J. A., Azodi, E., Narra, H. P., Patel, K., O’Neill, S., Cardwell, C., Hall, B. A., Wilson, J. M., & Hise, A. G. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1203239 · Cited by 98
Souza, A. C. O., & Amaral, A. C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00336 · Cited by 98
Impact of New Antifungal Breakpoints on Antifungal Resistance in Candida Species
Fothergill, A. W., Sutton, D. A., McCarthy, D. I., & Wiederhold, N. P. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03044-13 · Cited by 96
Anti-Candida activity of geraniol involves disruption of cell membrane integrity and function
Sharma, Y., Khan, L. A., & Manzoor, N. (2016) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2016.04.004 · Cited by 96
Antimicrobial Activity of Three Baccharis Species Used in the Traditional Medicine of Northern Chile
Morales, G., Paredes, A., Sierra, P., & Loyola, L. A. (2008) · Molecules · doi:10.3390/molecules13040790 · Cited by 95
CaNdt80 Is Involved in Drug Resistance in Candida albicans by Regulating CDR1
Chen, C.-G., Yang, Y.-L., Shih, H., Su, C.-L., & Lo, H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4505-4512.2004 · Cited by 94
Abu-Darwish, M. S., Cabral, C., Gonçalves, M. J., Cavaleiro, C., Cruz, M. T., Zulfiqar, A., Khan, I. A., Efferth, T., & Salgueiro, L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.06.023 · Cited by 93
Luo, Y., McLean, D. T. F., Linden, G. J., McAuley, D. F., McMullan, R., & Lundy, F. T. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00544 · Cited by 92
Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Pasqualotto, A. C., Thiele, K. O., & Goldani, L. Z. (2010) · PubMed · Cited by 90
Antifungal effects of phytocompounds on Candida species alone and in combination with fluconazole
Lü, M., Li, T., Wan, J., Li, X., Yuan, L., & Sun, S. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.10.021 · Cited by 90
Wirsching, S., Michel, S., Köhler, G., & Morschhäuser, J. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.2.400-404.2000 · Cited by 88
Papon, N., Noël, T., Florent, M., Gibot‐Leclerc, S., Jean, D., Chastin, C., Villard, J.-F., & Chapeland‐Leclerc, F. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00824-06 · Cited by 88
Ferreira, A. V., Prado, C. G., de Carvalho, R. R., Dias, K. S. T., & Dias, A. L. T. (2013) · Mycopathologia · doi:10.1007/s11046-013-9638-z · Cited by 84
Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis
Cernicka, J., & Šubík, J. (2006) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.12.005 · Cited by 83
Perea, S. H., Lopez-Ribot, J. L., Wickes, B. L., Kirkpatrick, W. R., Dib, O. P., Bachmann, S. P., Keller, S. M., Martínez, M., & Patterson, T. F. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1695-1703.2002 · Cited by 81
Transcriptional Analyses of Antifungal Drug Resistance in Candida albicans
Lyons, C. N., & White, T. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2296-2303.2000 · Cited by 79
Interactions between Triazoles and Amphotericin B against Cryptococcus neoformans
Barchiesi, F., Schimizzi, A. M., Caselli, F., Novelli, A., Fallani, S., Giannini, D., Arzeni, D., Cesare, S. D., Francesco, L. F. D., Fortuna, M., et al. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2435-2441.2000 · Cited by 78
McCormick, T. S., & Weinberg, A. (2010) · Periodontology 2000 · doi:10.1111/j.1600-0757.2010.00373.x · Cited by 76
Barchiesi, F., Francesco, L. F. D., & Scalise, G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1812 · Cited by 76
The antifungal effect of lactoferrin and lysozyme on Candida krusei and Candida albicans
Samaranayake, Y. H., Samaranayake, L. P., Wu, P., & SO, M. (1997) · Apmis · doi:10.1111/j.1699-0463.1997.tb05097.x · Cited by 75
Inhibition of Growth and Secreted Aspartyl Proteinase Production in Candida Albicans by Lysozyme
Wu, T., Samaranayake, L. P., Leung, W. K., & Sullivan, P. A. (1999) · Journal of Medical Microbiology · doi:10.1099/00222615-48-8-721 · Cited by 74
Lupetti, A., Brouwer, C. P. J. M., Bogaards, S. J. P., Welling, M. M., de Heer, E., Campa, M., van Dissel, J. T., Friesen, R. H. E., & Nibbering, P. H. (2007) · The Journal of Infectious Diseases · doi:10.1086/522427 · Cited by 73
Morici, P., Fais, R., Rizzato, C., Tavanti, A., & Lupetti, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167470 · Cited by 73
Novel strategies to fightCandidaspecies infection
Rodrigues, M. E., Silva, S. M., Azeredo, J., & Henriques, M. (2014) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2014.974500 · Cited by 70
Chen, Y., Lehman, V. N., Averette, A. F., Perfect, J. R., & Heitman, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057672 · Cited by 70
Fungal Biofilms and Antimycotics
Chandra, J., Zhou, G., & Ghannoum, M. A. (2005) · Current Drug Targets · doi:10.2174/138945005774912762 · Cited by 70
Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance
Niimi, M., Niimi, K., Takano, Y., Holmes, A. R., Fischer, F. J., Uehara, Y., & Cannon, R. D. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh456 · Cited by 69
Opportunistic yeast infections: candidiasis, cryptococcosis, trichosporonosis and geotrichosis
Vázquez‐González, D., Perusquía‐Ortiz, A. M., Hundeiker, M., & Bonifáz, A. (2013) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.12097 · Cited by 69
Perea, S. H., González, G. M., Fothergill, A. W., Sutton, D. A., & Rinaldi, M. G. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.5.1831-1833.2002 · Cited by 68
Siikala, E., Rautemaa, R., Richardson, M., Saxen, H., Bowyer, P., & Sanglard, D. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq354 · Cited by 66
Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata
Tscherner, M., Schwarzmüller, T., & Kuchler, K. (2011) · Pharmaceuticals · doi:10.3390/ph4010169 · Cited by 66
Brucker, K. D., Delattin, N., Robijns, S., Steenackers, H. P. L., Verstraeten, N., Landuyt, B., Luyten, W. H. M. L., Schoofs, L., Dovgan, B., Fröhlich, M., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03045-14 · Cited by 66
Antifungal Activity and Action Mechanism of Histatin 5-Halocidin Hybrid Peptides against Candida ssp
Han, J., Jyoti, M. A., Song, H., & Jang, W. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150196 · Cited by 66
Shields, R. K., Nguyen, M. H., Du, C., Press, E., Cheng, S., & Clancy, C. J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00999-10 · Cited by 65
Antibacterial Activity of Thyme and Lavender Essential Oils
Sienkiewicz, M., Łysakowska, M., Ciećwierz, J., Denys, P., & Kowalczyk, E. (2011) · Medicinal Chemistry · doi:10.2174/157340611797928488 · Cited by 65
Factors related to outcome of bloodstream infections due to Candida parapsilosis complex
Barchiesi, F., Orsetti, E., Osimani, P., Catassi, C., Santelli, F., & Manso, E. (2016) · BMC Infectious Diseases · doi:10.1186/s12879-016-1704-y · Cited by 64
Activity of crude extracts from Brazilian cerrado plants against clinically relevant Candida species
Correia, A. F., Silveira, D., Fonseca-Bazzo, Y. M., Magalhães, P. O., Fagg, C. W., da Silva, E. C., Gomes, S. M., Gandolfi, L., Pratesi, R., & Nóbrega, Y. K. D. M. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1164-3 · Cited by 63
Systemic Antifungal Agents: Current Status and Projected Future Developments
Seyedmousavi, S., Rafati, H., İlkit, M., Tolooe, A., Hedayati, M. T., & Verweij, P. E. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6515-1_5 · Cited by 63
Zhang, L., Xiao, M., Watts, M. R., Wang, H., Fan, X., Kong, F., & Xu, Y.-C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1086-6 · Cited by 62
Biologically Active Arborinane-Type Triterpenoids and Anthraquinones from Rubia yunnanensis
Fan, J., Kuang, B., Zeng, G., et al. (2011) · Journal of Natural Products · doi:10.1021/np2002918 · Cited by 60
Tangarife-Castaño, V. J., Correa-Royero, J., Zapata, B., Durán, C., Stashenko, E. E., & Mesa-Arango, A. C. (2011) · Infectio · doi:10.1016/s0123-9392(11)70080-7 · Cited by 58
Wong, S. S. W., Samaranayake, L. P., & Seneviratne, C. J. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.06.009 · Cited by 58
Wang, H., Kong, F., Sorrell, T. C., Wang, B., McNicholas, P., Pantarat, N., Ellis, D., Xiao, M., Widmer, F., & Chen, S. C. (2009) · BMC Microbiology · doi:10.1186/1471-2180-9-167 · Cited by 58
Vale-Silva, L. A., Gonçalves, M. S. T., Cavaleiro, C., Salgueiro, L., & Pinto, E. (2010) · Planta Medica · doi:10.1055/s-0029-1240799 · Cited by 57
Chang, W., Li, Y., Zhang, L., Cheng, A., & Lou, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041624 · Cited by 56
Chanda, S. V., Rakholiya, K., DHOLAKIA, K., & Baravalia, Y. K. (2013) · TURKISH JOURNAL OF BIOLOGY · doi:10.3906/biy-1203-41 · Cited by 55
Morey, A. T., de Souza, F. C., Santos, J. P., Pereira, C. A., Cardoso, J. D., Almeida, R. S., Costa, M. A., de Mello, J. C. P., Nakamura, C. V., Pinge‐Filho, P., et al. (2016) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201017666151223123712 · Cited by 55
Li, Y., Chen, W., Li, X., Li, H., Li, H., Wang, L., He, L., Yang, X., Wang, X., Huang, Y.-L., et al. (2013) · BMC Infectious Diseases · doi:10.1186/1471-2334-13-46 · Cited by 54
Pitman, S. K., Drew, R. H., & Perfect, J. R. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.607811 · Cited by 54
Alternative approaches to antifungal therapies
Mehra, T., Köberle, M., Braunsdorf, C., Mailänder‐Sánchez, D., Borelli, C., & Schaller, M. (2012) · Experimental Dermatology · doi:10.1111/exd.12004 · Cited by 53
Study of Candida albicans and its interactions with the host: A mini review
Tsai, P.-W., Chen, Y.-T., Hsu, P., & Lan, C. (2013) · Biomedicine · doi:10.1016/j.biomed.2012.12.004 · Cited by 53
Our 2014 approach to mucormycosis
Tacke, D., Koehler, P. A., Markiefka, B., & Cornely, O. A. (2014) · Mycoses · doi:10.1111/myc.12203 · Cited by 52
Kwamin, F., Nartey, N. O., Codjoe, F. S., et al. (2013) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.2442 · Cited by 52
Terças, A. G., Marques, S. G., Moffa, E. B., Alves, M. B., de Azevedo, C. D. M. P. E. S., Siqueira, W. L., & Monteiro, C. D. A. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00298 · Cited by 52
Anti-Biofilm Strategies: How to Eradicate Candida Biofilms?
Bink, A. (2011) · The Open Mycology Journal · doi:10.2174/1874437001105010029 · Cited by 51
Mechanisms of antifungal agent resistance.
Yang, Y. L., & Lo, H. (2001) · PubMed · Cited by 50
Antimicrobial activity and phytochemical characterization of Carya illinoensis
Bottari, N. B., Lopes, L. Q. S., Pizzuti, K., Alves, C. F. D. S., Corrêa, M. S., Bolzan, L. P., Zago, A. M., Vaucher, R. D. A., Boligon, A. A., Giongo, J. L., et al. (2017) · Microbial Pathogenesis · doi:10.1016/j.micpath.2017.01.037 · Cited by 50
Currently Used Antimycotics: Spectrum, Mode of Action and Resistance Occurrence
Francois, I., Aerts, A., Cammue, B., & Thevissen, K. (2005) · Current Drug Targets · doi:10.2174/138945005774912744 · Cited by 49 · cited 1×
“Griseofulvin was isolated from Penicillium griseofulvum, (Francois et al., 2005).”
Cited by
Antifungal drug-resistance mechanisms in Candida biofilms
Kaur, J., & Nobile, C. J. (2023) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102237 · Cited by 261
Mechanism of Candida pathogenesis: Revisiting the vital drivers
Mba, I. E., & Nweze, E. I. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03912-w · Cited by 143
Antimicrobial Activities of Natural Bioactive Polyphenols
Mandal, M. K., & Domb, A. J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060718 · Cited by 141
Anti-fungal properties and mechanisms of melittin
Memariani, H., & Memariani, M. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10701-0 · Cited by 58
Hodges, M. R., Ople, E., Wedel, P., Shaw, K. J., Jakate, A., Kramer, W. G., Marle, S. V., van Hoogdalem, E.-J., & Tawadrous, M. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01623-22 · Cited by 52
Metadata
- Authors
- de Oliveira Santos, G. C., Vasconcelos, C. C., Lopes, A. J. O., de Sousa Cartágenes, M. D. S., Filho, A. K. D. B., do Nascimento, F. R. F., Ramos, R. M., Pires, E. R. R. B., de Andrade, M. S., Rocha, F. M. G., & de Andrade Monteiro, C.
- Venue
- Frontiers in Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2018-07-03
- Volume
- 9
- Pages
- 1351-1351
- ISSN
- 1664-302X (ISSN-L)
- OpenAlex
- W2806610516
- Cited by
- 350
- References
- 260
- FWCI
- 17.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.